Protection of SAL B with H9C2 cells

Biological activities of salvianolic acid B fromSalvia miltiorrhizaon type 2 diabetes induced by high-fat diet and streptozotocin

(2015) Mingqing Huang et al.   PHARMACEUTICAL BIOLOGY

Salvianolic acid B inhibits platelets-mediated inflammatory response in vascular endothelial cells

(2015) Shixin Xu et al.   THROMBOSIS RESEARCH

Three pentacyclic triterpenes protect H9c2 cardiomyoblast cells against high-glucose-induced injury

(2014) C. Y. Chan et al.   FREE RADICAL RESEARCH

Co-Activation of Nuclear Factor-κB and Myocardin/Serum Response Factor Conveys the Hypertrophy Signal of High Insulin Levels in Cardiac Myoblasts

(2014) Rosalinda Madonna et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model

(2014) Beibei Luo et al.   PLoS One

Salvianolic Acid B Attenuates Toxin-Induced Neuronal Damage via Nrf2-Dependent Glial Cells-Mediated Protective Activity in Parkinson’s Disease Models

(2014) Jie Zhou et al.   PLoS One

Naringin Inhibits ROS-activated MAPK Pathway in High Glucose-induced Injuries in H9c2 Cardiac Cells

(2013) Jingfu Chen et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Doxorubicin-treated H9c2 cells: caution with luminescent ATP and Hoechst 33258 assays

(2013) Richard J. Calvert et al.   IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL

Depletion of 14-3-3 Protein Exacerbates Cardiac Oxidative Stress, Inflammation and Remodeling Process via Modulation of MAPK/NF-ĸB Signaling Pathways after Streptozotocin-induced Diabetes Mellitus

(2011) Rajarajan A. Thandavarayan et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Redox signaling in cardiac myocytes

(2011) Celio X.C. Santos et al.   FREE RADICAL BIOLOGY AND MEDICINE

Cardio-Protection of Salvianolic Acid B through Inhibition of Apoptosis Network

(2011) Lingling Xu et al.   PLoS One

Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis

(2010) Uthra Rajamani et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Medicinal Chemistry of Drugs Used in Diabetic Cardiomyopathy

(2010) E. Adeghate et al.   CURRENT MEDICINAL CHEMISTRY

Metabolomic strategy to study therapeutic and synergistic effects of tanshinone IIA, salvianolic acid B and ginsenoside Rb1 in myocardial ischemia rats

(2010) Yonghai Lu et al.   JOURNAL OF ETHNOPHARMACOLOGY

Ghrelin inhibits insulin resistance induced by glucotoxicity and lipotoxicity in cardiomyocyte

(2010) Cuiping Cao et al.   PEPTIDES

IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat

(2009) J. A. Ehses et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Diabetic Cardiomyopathy: Insights into Pathogenesis, Diagnostic Challenges, and Therapeutic Options

(2008) Ashish Aneja et al.   AMERICAN JOURNAL OF MEDICINE